GelStat Corp. (GSAC)

Market Cap	1.50M
Revenue (ttm)	349.73K
Net Income (ttm)	-372.95K
Shares Out	3.74B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,000
Average Volume	2,072,049
Open	0.0004
Previous Close	0.0004
Day's Range	0.0004 - 0.0004
52-Week Range	0.0002 - 0.0006
Beta	3.08
RSI	57.64
Earnings Date	May 6, 2025

About GelStat

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialt...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: GSAC

Financial Performance

In 2024, GelStat's revenue was $349,730, an increase of 133.89% compared to the previous year's $149,527. Losses were -$372,947, 77.5% more than in 2023.